Drug-eluting coronary stents.
The introduction and widespread use of coronary stents have been the most important advancement in the percutaneous treatment of coronary artery disease since the introduction of balloon angioplasty. Coronary artery stents reduce the rate of angiographic and clinical restenosis compared to balloon angioplasty. This angiographic restenosis was further reduced with the introduction of drug-eluting stents and hence further reduction in the frequency of major adverse cardiac events. Herein we present a comprehensive and up-to-date review about the use of drug-eluting stents in the treatment of coronary artery disease.
Salam
Amar M
AM
The North Hospital, State of Qatar.
Al Suwaidi
Jassim
J
Holmes
David R
DR
D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D000970:Antineoplastic Agents / Q000008:administration & dosage; D002317:Cardiovascular Agents / Q000008:administration & dosage; D002986:Clinical Trials as Topic; D023903:Coronary Restenosis / Q000503:physiopathology / Q000517:prevention & control*; D016503:Drug Delivery Systems; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D011474:Prosthesis Design; D020794:Receptor Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors; D015607:Stents
D000893:Anti-Inflammatory Agents; D000970:Antineoplastic Agents; D002317:Cardiovascular Agents; D007166:Immunosuppressive Agents; D020794:Receptor Protein-Tyrosine Kinases